Trials / Completed
CompletedNCT02512731
Intraoperative Fluid Therapy for Deceased Donor Renal Transplantation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- University Health Network, Toronto · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Delayed graft function (DGF) is defined as requirement for dialysis in the first week following kidney transplantation. DGF is a common complication occurring in 39% of the deceased donor renal transplants at the investigators' institution with significant cost and outcome implications. The 3 major risk factors for DGF are donor graft characteristics, recipient factors and perioperative management. The most easily modifiable of these factors is perioperative management, in particular intraoperative fluid therapy. The investigators propose to compare the amount of fluid administered using the current standard of care with the fluid administered when optimizing the cardiac output (CO) using Esophageal Doppler Monitoring (EDM) to guide fluid therapy. EDM measures blood flow in the descending aorta, optimizing stroke volume (SV) and cardiac output (CO) by indicating when fluid administration fails to produce an increase in CO.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Esophageal Doppler Monitor | Esophageal doppler monitoring (EDM) is a minimally invasive means of continuously measuring the cardiac output from the pattern of blood flow in the descending thoracic aorta. |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2015-09-01
- Completion
- 2016-12-01
- First posted
- 2015-07-31
- Last updated
- 2016-12-05
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02512731. Inclusion in this directory is not an endorsement.